Keywords: Sofosbuvir; Ledipasvir; Simultaneous determination; Partial least squares; Continues wavelet transform; Derivative spectrophotometry;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Binary mixtures; Wavelength-intersection ratio; UV/Vis spectrophotometry; Sofosbuvir; Ledipasvir;
Keywords: Ledipasvir; Sofosbuvir; First derivative spectrophotometric; Conventional dual wavelength method; Isosbestic point method; Absorbance correction method; Absorbance ratio method; Pharmaceutical dosage form; Uniformity of dosage unit; Simultaneous analysis;
Keywords: Direct-acting antivirals; Sofosbuvir; IFN-free regimens; Cryoglobulinemia; Lymphoma; HCV; Chronic kidney disease; Lichen planus;
Keywords: Direct-acting antivirals; Hepatitis C; Cirrhosis; Sofosbuvir; Ledipasvir; Paritaprevir; Ombitasvir; Simeprevir;
Keywords: Sofosbuvir; Hepatitis C virus; Ebola virus; RNA viruses; Emerging viruses; Antiviral chemistry
Keywords: Hepatitis C virus; Liver transplant; Direct-acting antivirals; Recurrent hepatitis C virus; Sofosbuvir; Simeprevir; Ledipasvir; Cholestatic hepatitis;
Keywords: Hepatitis C; Sofosbuvir; Simeprevir; Cost-effectivenessHepatitis C; Sofosbuvir; Simeprevir; Coste-efectividad
Keywords: Chronic hepatitis C; Genotype 1; Sofosbuvir; Cost–effectivenessHepatitis C crónica; Genotipo 1; Sofosbuvir; Coste-efectividad
Keywords: Hepatitis C virus; Interferons; Ribavirin; Sofosbuvir; Simeprevir
Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major
Keywords: DAA; Direct Acting Antiviral; DCV; Daclatasvir; ETR; End of Treatment Response; HCV; Hepatitis C Virus; PegINF-α; Pegylated Interferon-α; RBV; Ribavirin; RVR; Rapid Virological Response; SOF; Sofosbuvir; SVR12; Sustained Virological Response Post-treatm
Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
Keywords: Sofosbuvir; Daclatasvir; Simeprevir; DAA; Sustained virological response;
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Keywords: HCV; Glecaprevir; Pibrentasvir; Sofosbuvir; NS5A inhibitor resistance associated variant; P32 deletion; Human hepatocyte chimeric mouse; ASV; asunaprevir; DAAs; Direct-acting antivirals; DCV; daclatasvir; GLE; glecaprevir; HCV; hepatitis C virus; LDV; led
State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015
Keywords: DAAs; direct-acting antivirals; hepatitis C; Medicaid; sofosbuvir; specialty drugs;
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
Keywords: Zika virus; Yield reduction assay; Plaque assay; qRT-PCR; Sofosbuvir; Viral replication kinetics;
New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma
Keywords: Sofosbuvir; Ledipasvir; Simultaneous quantitation; High-performance thin-layer chromatography; Dual wavelength detection; Real rabbit plasma;
Effect of Sofosbuvir Plus Daclatasvir in Hepatitis C Virus Genotype-4 Patients: Promising Effect on Liver Fibrosis
Keywords: DAA; Direct Acting Anti-viral; FIB 4; Fibrosis Score 4; HCV; Hepatitis C Virus; IL-18; Interleukin 18; INF; Interferon; NS; Non-Structural; PCR; Polymerase Chain Reaction; RFLP; Restriction Fragment Length Polymorphism; RNA; Ribonucleic Acid; SNPs; Single
5â² UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, Egypt
Keywords: HCV; Genotypes; NS5B; 5â² UTR; Phylogenetic tree; Sofosbuvir;
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Keywords: Direct-acting Antiviral; DAA; Short-duration; Pangenotypic; ALT; alanine aminotransferase; CI; confidence interval; DAA; direct-acting antiviral; G/P; glecaprevir/pibrentasvir; HCV; hepatitis C virus; IFN; interferon; ITT; intention-to-treat; LLOQ; lower
Pharmacokinetics, Safety, and Tolerability of the Direct-acting Hepatitis C Antiviral Sofosbuvir in HealthyChineseSubjects
Keywords: Chinese; healthy; hepatitis C virus; pharmacokinetics; sofosbuvir;
Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir
Keywords: Chronic hepatitis C; Auditory functions; Otoacoustic emission; Sofosbuvir;
Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India
Keywords: DAA; direct acting antivirals; DDLT; deceased donor liver transplant; ETR; end of treatment response; HCV; hepatitis C; LDLT; living donor liver transplantation; RVR; rapid virological response; SVR12; sustained virological response at 12 weeks; hepatitis
Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals
Keywords: Simulation Model; Sofosbuvir; Health Economics; DAA; oral direct-acting antiviral; HCV; hepatitis C virus; ICER; incremental cost-effectiveness ratio; LT; liver transplantation; MELD; Model for End-stage Liver Disease; QALY; quality-adjusted life year; SV
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems
Keywords: HLCs; Antiviral; Primary Isolates; Personalized Medicine; ALB; albumin; AFP; alpha-fetoprotein; bFGF; basic fibroblast growth factor; BM; basal medium; CsA; cyclosporine A; DE; definitive endoderm; DMSO; dimethyl sulfoxide; Dox; doxycycline; ESC; embryoni
Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir
Keywords: Ledipasvir; Sofosbuvir; Spectroflurimetry; Sofolanork plus;
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients
Keywords: UPLC-MS/MS; ultra performance liquid chromatograpy; LOD; limit of detection; LOQ; limit of quantification; HCV; hepatitis C virus; NS5A/5B; non-structural 5A/5B; SVR; sustained virological response; Sofosbuvir; GS-331007; Daclatasvir; DAA; HCV; Therapeu
Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis
Keywords: Sofosbuvir; Daclatasvir; HPTLC-dual wavelength spectrodensitometry; Simultaneous determination; Real human plasma; Pharmaceutical formulations;
Sofosbuvir/velpatasvir for 12â¯weeks in genotype 1-4 HCV-infected liver transplant recipients
Keywords: Direct-acting antiviral; Hepatitis C; Liver transplant; NS5A inhibitor; Sofosbuvir; Velpatasvir;
Impact of Direct Acting Antiviral Therapy for Treatment of Hepatitis C Genotypes 1, 3 and 4: A Real Life Experience from India
Keywords: DAA; Direct Acting Antiviral; DCV; Daclatasvir; EASL; European Association of Study of the Liver (EASL); ETR; End of Treatment Response; HBV; Hepatitis B; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HIV; Human Immunedeficiency Virus; ITT; inten
Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study
Keywords: HPLC-UV; Human urine; Human plasma; Dissolution test; Sofosbuvir; Daclatasvir;
Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4
Keywords: Egypt; Hepatitis C virus; Ribavirin; Sofosbuvir; PEG-IFNα-2a;
Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system
Keywords: Hepatitis A virus; Reporter system; Antivirals; Sofosbuvir; Interferon;
Patient-Reported Outcomes Following Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Velpatasvir, With or Without Voxilaprevir
Keywords: POLARIS-1 and POLARIS-4; Fatigue; Work Productivity; Health Utility; Vitality; CLDQ-HCV; Chronic Liver Disease Questionnaire-HCV Version; DAAs; direct-acting antiviral agents; FACIT-F; Functional Assessment of Chronic Illness Therapy-Fatigue; HCV; hepatit
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4
Keywords: HCV; Ravidasvir; PPI-668; Sofosbuvir; Genotype-4; Sustained virologic response (SVR);
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Keywords: RESIST-HCV; Liver Cancer Risk; Reduction; Sofosbuvir; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; DAAs; direct-antiviral agents; EGS; esophageal gastroscopy; EV; esophageal varices; HCC; hepatocellular carcinoma; HCV; hepatitis C virus;
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals
Keywords: HCV; RASs; DAA; Virologic Treatment Failure; DAA; direct-acting antiviral; DCV; daclatasvir; EOT; end of treatment; GT; genotype; HCV; hepatitis C virus; LDV; ledipasvir; NS; nonstructural protein; PCR; polymerase chain reaction; PEG IFN; pegylated interf
Consenso Mexicano para el Tratamiento de la Hepatitis C
Keywords: Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; AAD; antivirales de acción directa; AASLD; Asociación Americana para el Estud
The Mexican consensus on the treatment of hepatitis C
Keywords: Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report
Keywords: Recurrent mixed cryoglobulinemia syndrome; hepatitis C virus (HCV); direct antiviral agents; cryoprecipitate; sustained virological response (SVR); sofosbuvir; kidney biopsy; membranoproliferative glomerulonephritis; HCV RNA; viral load; renal involvement
Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC-MS/MS technique: Application to a bioequivalence study
Keywords: Sofosbuvir; HPLC; UV detection; Bioequivalence study;
Predictors of hepatitis C virus recurrence after living donor liver transplantation: Mansoura experience
Keywords: Hepatitis C virus; Liver transplantation; Interferon; Sofosbuvir; Graft rejection;
Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen
Keywords: DAA; daclatasvir; HCV; hemodialysis; India; sofosbuvir;
Response Tailored Protocol Versus the Fixed 12Â Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
Keywords: Chronic hepatitis C infection; Sofosbuvir; Daclatasvir; Response tailored therapy; Very rapid virologic response; SVR12;
Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study
Keywords: LC-MS/MS; Sofosbuvir; Ledipasvir; GS-331007; Human plasma; Pharmacokinetic study; Hepatitis C;
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevirâ±âribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study
Keywords: Sofosbuvir; Simeprevir; HIV/HCV co-infection; Sustained virological response; SVR;
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
Keywords: Chronic hepatitis C; DAA treatment; Immune response; miRNA-122; HCV; hepatitis C virus; IP-10; interferon gamma-induced protein; CHC; chronic hepatitis C; DAAs; direct acting antivirals; SVR; sustained virological response; miR-122; microRNA-122; RAS; res
Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C
Keywords: Chronic hepatitis; Elderly; Ribavirin; Sofosbuvir;
Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study
Keywords: Drugs; Generic; Ledipasvir; Sofosbuvir; Hepatitis C;
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience
Keywords: HCV; Genotype 2; Sofosbuvir; Ribavirin; Cirrhosis;